Adjust your brief

The preview updates as you change things. Nothing is kept until you save.

Start from
Briefs

A brief you don't subscribe to adds only its free latest edition.

Reading time
Stories open at
Topics

Coming after tag review. Today's automatic tags aren't reliable enough to choose stories.

Reset

Preview · 8 items · about 10 min

  1. Erasca’s pan-RAS pill ERAS-0015 drew confirmed responses in 44% of 25 previously treated pancreatic cancer patients2 min
  2. The S&P 500 closes in correction as chip stocks fall about 10%2 min
  3. Why beef costs more this year1 min
  4. Revolution Medicines reported first-line data for daraxonrasib plus chemotherapy in metastatic pancreatic cancer1 min
  5. Anthropic closes its IPO at about $119.5 billion combined; the stock falls 8.98%1 min
  6. Who gets leave, and who does the care1 min
  7. Actinogen’s pivotal Xanamem trial in Alzheimer’s disease missed its primary endpoint1 min
  8. Why there’s no tested way to can pumpkin butter at home1 min